Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary Hypercholesterolemia

Novartis

Status and phase: Completed; Phase 3

Conditions: Mixed Dyslipidemia; Hypercholesterolemia

Treatments: Drug: Fluvastatin

Study type: Interventional

Funder types: Industry

Identifiers

NCT00136799

CXUO320B2302

Details and patient eligibility

About

The purpose of the study is to evaluate the safety and tolerability of fluvastatin 80 mg in a Chinese population. This study is not recruiting patients in the US.

Enrollment: 325 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Mixed dyslipidemia
• Primary hypercholesterolemia

Exclusion criteria

• Pregnant or lactating women
• Age > 18 years

Other protocol-defined inclusion and exclusion criteria may apply.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind